VIA
INBX icon

Virtus Investment Advisers’s Inhibrx INBX Stock Holding History

Virtus Investment Advisers’s Portfolio INBX Stock Details INBX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$336K Buy
3,549
+124
+4% +$12.4K 0.08% 357
2026
Q1 		$230K Buy
3,425
+82
+2% +$6.08K 0.06% 323
2025
Q4 		$264K Buy
+3,343
New +$228K 0.07% 305

Other funds holding INBX

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $104B AUM 28.3% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $27.9B AUM 51.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Virtus Investment Advisers's INBX Position: Q2 2026 in Review

Virtus Investment Advisers increased its Inhibrx (INBX) stake by 3.6% in Q2 2026, buying an estimated $12.4K and bringing the position to 3,549 shares worth $336K. The position accounts for 0.08% of the portfolio, ranked #357.

Virtus Investment Advisers first reported a position in INBX in Q4 2025 and has held it in 3 quarters since. 162 funds tracked by Wall St. Rank hold INBX as of Q2 2026.

  • Virtus Investment Advisers held 3,549 shares of Inhibrx worth $336K as of Q2 2026.
  • Virtus Investment Advisers bought 124 Inhibrx shares in Q2 2026, an estimated $12.4K.
  • Inhibrx made up 0.08% of Virtus Investment Advisers's portfolio in Q2 2026, its #357 holding.
  • Virtus Investment Advisers first reported a position in Inhibrx in Q4 2025 and has held it in 3 quarters since.
  • 162 funds tracked by Wall St. Rank held Inhibrx as of Q2 2026.

Based on Virtus Investment Advisers's 13F filing for Q2 2026, filed 11 Aug 2026.